Li Mengzhen, Xia Bing, Wang Yi, You M James, Zhang Yizhuo
Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer; 300060, China.
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
J Cancer. 2019 Oct 15;10(24):6154-6160. doi: 10.7150/jca.31752. eCollection 2019.
Multiple myeloma (MM) is the second most prevalent hematological malignancy. In spite of the remarkable progress in understanding the biology and therapy of MM, curing this disease remains difficult, which calls for more effective treatment strategies. As vital communicators between different cells, exosomes have been verified to be crucial to cancer diagnosis, treatment, and prognosis. Exosomes in MM patients show a different expression profile compared with those in healthy individuals. In this review, we summarize potential therapy roles exosomes may play in MM. The specific expression of certain components in exosomes may provide therapeutic targets. Moreover, tumor-derived exosomes and their modified products can be developed into vaccines for anti-tumor immunity. In addition, the natural nano structure of exosomes makes them excellent carriers for drug delivery. Thus, a more rigorous investigation into exosomes will pave the way for novel tumor therapies in MM patients.
多发性骨髓瘤(MM)是第二常见的血液系统恶性肿瘤。尽管在理解MM的生物学特性和治疗方面取得了显著进展,但治愈这种疾病仍然困难,这需要更有效的治疗策略。作为不同细胞之间的重要通讯者,外泌体已被证实对癌症的诊断、治疗和预后至关重要。与健康个体相比,MM患者的外泌体表现出不同的表达谱。在本综述中,我们总结了外泌体在MM中可能发挥的潜在治疗作用。外泌体中某些成分的特异性表达可能提供治疗靶点。此外,肿瘤来源的外泌体及其修饰产物可被开发成用于抗肿瘤免疫的疫苗。此外,外泌体的天然纳米结构使其成为药物递送的优良载体。因此,对外泌体进行更严格的研究将为MM患者的新型肿瘤治疗铺平道路。